...
首页> 外文期刊>Stroke: A Journal of Cerebral Circulation >Intravenous Thrombolysis of Basilar Artery Occlusion: Predictors of Recanalization and Outcome.
【24h】

Intravenous Thrombolysis of Basilar Artery Occlusion: Predictors of Recanalization and Outcome.

机译:基底动脉闭塞的静脉溶栓治疗:再通和结果的预测指标。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND AND PURPOSE: Basilar artery occlusion has a high mortality rate (85% to 95%) if untreated. We describe a large single-center cohort treated mostly with intravenous alteplase and heparin. METHODS: The cohort included 116 patients with angiography-verified basilar artery occlusion. We studied baseline characteristics, frequencies of recanalization and symptomatic intracranial hemorrhage, and 3-month outcome (modified Rankin Scale [mRS]). RESULTS: Thirty patients (25.9%) had mRS 0 to 2, 42 patients (36.2%) had moderate outcome (mRS, 0-3), 26 patients (22.4%) required daily help (mRS, 4-5), and 48 patients (41.4%) died. Eighteen patients (15.7%) developed symptomatic intracranial hemorrhage. In patients with post-treatment angiogram available (n=91), 59 patients (64.8%) had a complete or partial recanalization. Radiological location of basilar artery occlusion was known in 55 of 91 instances, and recanalization was associated directly with clot location at the top-of-basilar (odds ratio, 4.8 [1.1-22]; P=0.048). Independent outcome (mRS 0-2) was associated with lower age and National Institutes of Health Stroke Scale (NIHSS) score at baseline. Age, nil or minimal recanalization, and symptomatic intracranial hemorrhage were independently associated with fatal outcome. Sixteen of 71 patients (22.5%) who presented with coma eventually reached moderate outcome, and additional 8 patients (11.3%) progressed to mRS 4. CONCLUSIONS: Whereas recanalization after intravenous thrombolysis strongly predicts survival and moderate outcome, therapeutic techniques should concentrate on clot location. Although most adverse baseline variables, age, symptom severity, but also coma are beyond control, it should not preclude thrombolysis, which may permit independent survival.
机译:背景与目的:如果不进行治疗,基底动脉闭塞症的死亡率很高(85%至95%)。我们描述了一个大型的单中心队列,主要采用静脉阿替普酶和肝素治疗。方法:该队列包括116例经血管造影证实的基底动脉闭塞的患者。我们研究了基线特征,再通和出现症状性颅内出血的频率以及3个月的预后(改良的Rankin量表[mRS])。结果:30例患者(25.9%)的mRS为0至2,42例患者(36.2%)的结果为中度(mRS,0-3),26例患者(22.4%)的需要每日帮助(mRS,4-5),48例患者(41.4%)死亡。 18名患者(15.7%)出现了症状性颅内出血。在可获得治疗后血管造影的患者中(n = 91),有59例患者(64.8%)进行了完全或部分再通。 91例中有55例已知基底动脉闭塞的放射学位置,并且再通气与基底基底顶部的血块位置直接相关(比值比为4.8 [1.1-22]; P = 0.048)。独立结局(mRS 0-2)与较低年龄和美国国立卫生研究院卒中量表(NIHSS)评分相关。年龄,零或最小再通以及症状性颅内出血均与致命结局独立相关。出现昏迷的71名患者中有16名(22.5%)最终达到了中等程度的结局,另有8例(11.3%)进展为mRS 4。位置。尽管大多数不利的基线变量,年龄,症状严重程度以及昏迷都无法控制,但不应排除溶栓作用,因为溶栓作用可以独立生存。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号